These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
202 related articles for article (PubMed ID: 28233473)
1. Genetic variants in telomere-maintenance genes are associated with ovarian cancer risk and outcome. Sun Y; Tao W; Huang M; Wu X; Gu J J Cell Mol Med; 2017 Mar; 21(3):510-518. PubMed ID: 28233473 [TBL] [Abstract][Full Text] [Related]
2. Polymorphisms in telomere-associated genes, breast cancer susceptibility and prognosis. Varadi V; Brendle A; Brandt A; Johansson R; Enquist K; Henriksson R; Svenson U; Tavelin B; Roos G; Hemminki K; Lenner P; Försti A Eur J Cancer; 2009 Nov; 45(17):3008-16. PubMed ID: 19766477 [TBL] [Abstract][Full Text] [Related]
3. Genetic variants in the TEP1 gene are associated with prostate cancer risk and recurrence. Gu C; Li Q; Zhu Y; Qu Y; Zhang G; Wang M; Yang Y; Wang J; Jin L; Wei Q; Ye D Prostate Cancer Prostatic Dis; 2015 Dec; 18(4):310-6. PubMed ID: 26238235 [TBL] [Abstract][Full Text] [Related]
4. Genetic variants in matrix metalloproteinase genes as disposition factors for ovarian cancer risk, survival, and clinical outcome. Wang Y; Ye Y; Lin J; Meyer L; Wu X; Lu K; Liang D Mol Carcinog; 2015 Jun; 54(6):430-9. PubMed ID: 25867973 [TBL] [Abstract][Full Text] [Related]
5. Genetic variants in eleven telomere-associated genes and the risk of incident cardio/cerebrovascular disease: The Women's Genome Health Study. Zee RY; Ridker PM; Chasman DI Clin Chim Acta; 2011 Jan; 412(1-2):199-202. PubMed ID: 20937264 [TBL] [Abstract][Full Text] [Related]
6. Telomere length and genetic variation in telomere maintenance genes in relation to ovarian cancer risk. Terry KL; Tworoger SS; Vitonis AF; Wong J; Titus-Ernstoff L; De Vivo I; Cramer DW Cancer Epidemiol Biomarkers Prev; 2012 Mar; 21(3):504-12. PubMed ID: 22267287 [TBL] [Abstract][Full Text] [Related]
7. Genetic variants in telomerase reverse transcriptase (TERT) and telomerase-associated protein 1 (TEP1) and the risk of male infertility. Yan L; Wu S; Zhang S; Ji G; Gu A Gene; 2014 Jan; 534(2):139-43. PubMed ID: 24269974 [TBL] [Abstract][Full Text] [Related]
8. Genetic variants in the fibroblast growth factor pathway as potential markers of ovarian cancer risk, therapeutic response, and clinical outcome. Meng QH; Xu E; Hildebrandt MA; Liang D; Lu K; Ye Y; Wagar EA; Wu X Clin Chem; 2014 Jan; 60(1):222-32. PubMed ID: 24146310 [TBL] [Abstract][Full Text] [Related]
9. Genetic variants in telomere-maintenance genes and bladder cancer risk. Chang J; Dinney CP; Huang M; Wu X; Gu J PLoS One; 2012; 7(2):e30665. PubMed ID: 22363464 [TBL] [Abstract][Full Text] [Related]
11. Genetic variation in five genes important in telomere biology and risk for breast cancer. Savage SA; Chanock SJ; Lissowska J; Brinton LA; Richesson D; Peplonska B; Bardin-Mikolajczak A; Zatonski W; Szeszenia-Dabrowska N; Garcia-Closas M Br J Cancer; 2007 Sep; 97(6):832-6. PubMed ID: 17848914 [TBL] [Abstract][Full Text] [Related]
12. The association of telomere length and genetic variation in telomere biology genes. Mirabello L; Yu K; Kraft P; De Vivo I; Hunter DJ; Prescott J; Wong JY; Chatterjee N; Hayes RB; Savage SA Hum Mutat; 2010 Sep; 31(9):1050-8. PubMed ID: 20597107 [TBL] [Abstract][Full Text] [Related]
13. Associations of TERC Single Nucleotide Polymorphisms with Human Leukocyte Telomere Length and the Risk of Type 2 Diabetes Mellitus. Al Khaldi R; Mojiminiyi O; AlMulla F; Abdella N PLoS One; 2015; 10(12):e0145721. PubMed ID: 26720590 [TBL] [Abstract][Full Text] [Related]
14. Prognostic impact of telomere maintenance gene polymorphisms on hepatocellular carcinoma patients with chronic hepatitis B. Jung SW; Park NH; Shin JW; Park BR; Kim CJ; Lee JE; Shin ES; Kim JA; Chung YH Hepatology; 2014 May; 59(5):1912-20. PubMed ID: 23907815 [TBL] [Abstract][Full Text] [Related]
15. Telomere structure and maintenance gene variants and risk of five cancer types. Karami S; Han Y; Pande M; Cheng I; Rudd J; Pierce BL; Nutter EL; Schumacher FR; Kote-Jarai Z; Lindstrom S; Witte JS; Fang S; Han J; Kraft P; Hunter DJ; Song F; Hung RJ; McKay J; Gruber SB; Chanock SJ; Risch A; Shen H; Haiman CA; Boardman L; Ulrich CM; Casey G; Peters U; Amin Al Olama A; Berchuck A; Berndt SI; Bezieau S; Brennan P; Brenner H; Brinton L; Caporaso N; Chan AT; Chang-Claude J; Christiani DC; Cunningham JM; Easton D; Eeles RA; Eisen T; Gala M; Gallinger SJ; Gayther SA; Goode EL; Grönberg H; Henderson BE; Houlston R; Joshi AD; Küry S; Landi MT; Le Marchand L; Muir K; Newcomb PA; Permuth-Wey J; Pharoah P; Phelan C; Potter JD; Ramus SJ; Risch H; Schildkraut J; Slattery ML; Song H; Wentzensen N; White E; Wiklund F; Zanke BW; Sellers TA; Zheng W; Chatterjee N; Amos CI; Doherty JA; Int J Cancer; 2016 Dec; 139(12):2655-2670. PubMed ID: 27459707 [TBL] [Abstract][Full Text] [Related]
16. Genetic variants in MicroRNA biosynthesis pathways and binding sites modify ovarian cancer risk, survival, and treatment response. Liang D; Meyer L; Chang DW; Lin J; Pu X; Ye Y; Gu J; Wu X; Lu K Cancer Res; 2010 Dec; 70(23):9765-76. PubMed ID: 21118967 [TBL] [Abstract][Full Text] [Related]
17. Association between single nucleotide polymorphisms (SNPs) of XRCC2 and XRCC3 homologous recombination repair genes and ovarian cancer in Polish women. Michalska MM; Samulak D; Romanowicz H; Jabłoński F; Smolarz B Exp Mol Pathol; 2016 Apr; 100(2):243-7. PubMed ID: 26801223 [TBL] [Abstract][Full Text] [Related]
18. Multiple genetic variants in telomere pathway genes and breast cancer risk. Shen J; Gammon MD; Wu HC; Terry MB; Wang Q; Bradshaw PT; Teitelbaum SL; Neugut AI; Santella RM Cancer Epidemiol Biomarkers Prev; 2010 Jan; 19(1):219-28. PubMed ID: 20056641 [TBL] [Abstract][Full Text] [Related]